StockNews.com began coverage on shares of Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) in a report released on Monday morning. The firm issued a hold rating on the oil and gas company’s stock.
Separately, The Goldman Sachs Group reduced their price target on Calumet Specialty Products Partners from $19.00 to $17.00 and set a buy rating for the company in a report on Thursday, March 21st.
Get Our Latest Stock Report on CLMT
Calumet Specialty Products Partners Trading Down 3.8 %
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) last announced its quarterly earnings results on Friday, February 23rd. The oil and gas company reported ($0.59) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.40). The firm had revenue of $976.50 million during the quarter, compared to analyst estimates of $856.71 million. Calumet Specialty Products Partners’s revenue was down 2.3% compared to the same quarter last year. During the same period last year, the company posted ($0.21) EPS. Research analysts anticipate that Calumet Specialty Products Partners will post -0.52 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the stock. Wasserstein Debt Opportunities Management L.P. bought a new position in shares of Calumet Specialty Products Partners in the 4th quarter valued at approximately $119,698,000. Raymond James & Associates raised its stake in shares of Calumet Specialty Products Partners by 11.0% in the 1st quarter. Raymond James & Associates now owns 504,368 shares of the oil and gas company’s stock valued at $7,495,000 after acquiring an additional 50,008 shares in the last quarter. Grizzlyrock Capital LLC bought a new position in shares of Calumet Specialty Products Partners in the 4th quarter valued at approximately $8,909,000. Corient Private Wealth LLC bought a new position in shares of Calumet Specialty Products Partners in the 4th quarter valued at approximately $8,312,000. Finally, Barclays PLC raised its stake in shares of Calumet Specialty Products Partners by 38.1% in the 3rd quarter. Barclays PLC now owns 200,870 shares of the oil and gas company’s stock valued at $3,837,000 after acquiring an additional 55,370 shares in the last quarter. 34.41% of the stock is owned by institutional investors.
Calumet Specialty Products Partners Company Profile
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Performance brands; Montana/Renewables; and Corporate segments.
See Also
- Five stocks we like better than Calumet Specialty Products Partners
- Are Penny Stocks a Good Fit for Your Portfolio?
- High-Yield Texas Instruments Could Hit New Highs Soon
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What is a Death Cross in Stocks?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.